{
    "answer": "I could not find the specific immunology segment net sales data for Cosentyx in the full year 2024, reported and constant currency, within the specified Novartis supplementary financial data report (Q4 2024 Condensed Financial Report \u2013 Supplementary Data).",
    "ground_truth": "$6,141,000,000; 23% increase (reported); 25% increase (constant currency)",
    "rewards": [
        0,
        0,
        0,
        0,
        0
    ],
    "reward_sum": 0,
    "turns": 5,
    "search count": 3,
    "script count": 0,
    "summary count": 0,
    "context lengths": [
        880,
        2426,
        3864,
        4952,
        5520
    ]
}